Fig. 2
From: Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China
Survival analysis based on interstitial lung disease (ILD), pulmonary arterial hypertension (PAH), cardiac involvement and pulmonary dysfunction. SSc, systemic sclerosis; FVC, forced vital capacity; DLCO, diffusing capacity for carbon monoxide
